PLX
Protalix Biotherapeutics Inc
2.70$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.6% | +6.4% | +1.9% | -32.7% | +19.3% | +0.6% | +6.2% | +4.8% | +0.1% | +24.3% | +7.8% | |
| – | -3.7% | +7.8% | +2.6% | -38.1% | +25.5% | +0.7% | +8.2% | +1.6% | +0.3% | +29.5% | +6.8% | |
| – | +15.8% | +15.1% | -14.0% | +17.1% | -27.9% | -1.5% | -8.0% | -23.7% | +7.6% | +184.1% | -34.3% | |
| – | +8.7% | +8.8% | -7.1% | -39.1% | +27.1% | -0.2% | -3.9% | -12.1% | +3.1% | +71.1% | -21.5% | |
| – | -41.0% | -28.7% | +169.4% | -78.3% | +32.5% | +60.7% | +102.0% | +52.8% | -38.7% | -66.8% | +461.5% | |
| – | -11.8% | +17.3% | -7.3% | -17.0% | +23.5% | -8.2% | +8.3% | +0.6% | +21.0% | +18.4% | +6.0% | |
| – | – | – | – | – | -2.6% | -0.7% | -2.1% | +28.6% | +0.4% | – | – | |
| – | +3.1% | +18.0% | +4.9% | -53.7% | +3.7% | -5.0% | -0.4% | +2.7% | +16.2% | +2.9% | +10.9% | |
| – | +5.0% | +20.4% | +5.7% | -58.2% | +5.8% | -5.1% | -0.9% | -8.9% | +20.8% | +3.3% | +14.6% | |
| – | +0.7% | +1.0% | +6.6% | -93.5% | -0.5% | -5.0% | +3.3% | -5.1% | -0.9% | +3.5% | +16.3% | |
| – | +38.7% | -27.2% | +29.2% | -22.9% | +44.6% | -9.1% | +62.3% | -19.6% | -2.2% | -18.5% | +51.8% | |
| – | -12.2% | -11.3% | -4.0% | +13.5% | +33.2% | +4.6% | +10.4% | +6.0% | -8.8% | +39.4% | +6.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.9% | +0.1% | +0.4% | +10.8% | -0.2% | -5.5% | +6.1% | -0.6% | -2.8% | +5.7% | -0.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.